Abstract. Fibronectin (FN) is a multidomain extracellular matrix protein that induces attachment and chemotactic migration of fibroblastic cells. In this study we analyzed the molecular determinants involved in the FN-induced chemotactic migration of normal and SV40-transformed 3T3 cells. Two different monoclonal antibodies to the cell-binding site of FN blocked chemotaxis to a 140-kD FN fragment (Ca 140) containing the cell-binding domain. A monoclonal antibody to a determinant distant from the cell-binding site did not affect chemotaxis. A synthetic tetrapeptide, RGDS, which represents the major cell-attachment sequence, was able to compete with FN and the Ca 140 fragment in chemotaxis assays, but this peptide itself had no significant chemotactic activity. A larger peptide encompassing this sequence, GRGDSP, was chemotactic, while the peptide GRGESE where a glutamic acid residue was substituted for aspartic acid, was inactive. Chemotactic migration could be prevented in a dosedependent manner by a rabbit polyclonal antiserum to a 140-kD cell surface FN receptor. This antibody was more effective on normal than on transformed 3T3 cells. Neither the anti-FN receptor antiserum nor a monoclonal antibody to the cell-binding site of FN blocked migration induced by another potent chemoattractant, platelet-derived growth factor. These data indicate that FN-induced chemotaxis of 3T3 and SV3T3 cells is mediated via the RGDS cell-attachment site of FN and the 140-kD cell surface FN receptor. The interaction is specific and can be altered by transformation.
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number of studies indicate that fibronectin (FN) ~ and certain FN fragments are potent chemoattractants for fibroblastic cells (5, 17, 27, 34, 41, 44, 47) . Presumably this activity is important in wound healing where fibroblasts from the surrounding tissues are recruited to the site of damage to produce the matrix molecules necessary for full repair (48) . The rate of repair is believed to be related to the numbers of cells recruited to the wound site and thereby to the level of chemoattractants and the duration of their production. Chemotaxis to FN may also be involved in pathological situations including fibrosis and tumor cell metastasis (2, 22, 28, 30, 31, 44, (52) (53) (54) . The chemotactic region of FN has been localized within a large cell-binding chymotryptic 160-kD peptide (47) and in a cathepsin D-derived 140-kD peptide which lacks gelatin-binding activity (3, 5, 41) .
Studies with various chemoattractants in eukaryotic and prokaryotic cells show that the responding cells have receptors which bind the attractant and elicit the intracellular events that direct cell movement (6, 12, 22, 24, 36, 56) . Here we have attempted to determine if the chemotactic response of 3T3 cells and their SV40-transformed counterpart to FN occurs through the RGD-attachment site of the molecule (37, 40) and an FN receptor (Mr 140,000) (18, 19, 51) . Studies with antibodies to the cell-binding site in FN, with antibodies to the FN receptor, and with various synthetic peptides suggest that the cell-attachment site of FN also elicits chemotaxis.
and glutamine (300 ~tg/ml), and were harvested by trypsin treatment (0.05 % trypsin, 0.02 % EDTA in PBS, pH 7.4).
Chemoattractants FN (Sigma, Munich, FRG) was diluted with DME to 30 I.tg/ml. Ca 140, a large cathepsin D fragment, was prepared from purified human plasma FN by mild digestion (45) . The preparation, purification, and electrophoretic purity of the Ca 140 fragment has been previously described (16, 45) . Ca 140 was shown previously to be a potent chemoattractant (3, 5) and was used here at 20 p.g/rnl. Platelet-derived growth factor (PDGF) was purchased from Collaborative Research, Inc. (Lexington, MA) and used as a chemoattractant at 5 ng/ml (46) . The tetrapeptide RGDS was purchased from Nova Biochemical AG (L~iwfelfingen, Switzerland). The hexapeptides GRGDSP and GRGESP were synthesized by Prof. P. Neri of Centro di Ricerca Interdipartimentale fer le Scienze Mediche Avantate (CRISMA, University of Siena, Siena, Italy), using an automated peptide synthesizer (model No. 430A; Applied Biosystems, Inc., Foster City, CA) equipped with the chemistry provided by the manufacturer. After cleavage from the resin with hydrogen fluoride the peptides were purified by two cycles of chromatography on Sephadex G10 in water, lyophilized, and stored at -20 C.
Antibodies
A317 and A286 are two distinct monoclonal antibodies reacting with determinants within the COOH-terminus of peptide Ca 140 (16, 45) . These antibodies were kindly provided by M. Schachner (Institiit fiir Neurobiologie, Heidelberg, FRG). The monoclonal antibody 3E3, a gift of M. Pierschbacher (La Jolla Cancer Research Foundation, La Jolla, CA), reacts with the cell-attachment domain of FN (39) . Goat anti-FN serum was a gift of Klaus von der Mark (Max-Planck-Institut, Martinsried, FRG). The antibaby hamster kidney (BHK) serum reacting with the 140-kD FN receptor on BHK cells has been previously characterized (18, 19, 51 ). An IgG fraction from this antiserum was prepared by affinity chromatography on Protein A-Sepharose. Immunoprecipitation oftbe cell surface receptor proteins was performed as previously described (51) . The 135-kD component of the FN receptor was purified from SR/BALB/c 3T3 cell membranes on lectin-Sepharose column followed by hydroxyapatite chromatography (20) . For some experiments the anti-BHK antiserum was adsorbed on a receptor affinity column.
Chemotaxis Assays
These assays were carried out in Boyden chambers as described previously (42) . Cells were harvested in trypsin (0.05%) and EDTA (0.01%) in PBS (pH 7.4). The cells were recovered by centrifugation, resuspended in DME, recentrifuged, and then resuspended in DME without serum. Cells (1 x 105) were added to the upper compartment (0.8 ml) of the Boyden chamber and the lower compartment (0.2 ml) was filled with media usually containing a chemoattractant, in the presence or absence of different antibodies. We analyzed the effect of different monoclonal antibodies recognizing Ca 140 (which contains the cell-binding domain) on the migration of 3T3 cells to Ca 140 itself (20 p.g/ml) and to PDGF (5 ng/ml). A317 and 3E3 are antibodies directed to the cell-binding site in Ca 140, while A286 recognizes a determinant in a more NH2-terminal region of the fragment. Data are expressed as percent of maximal migration as compared to the chemoattractant alone. Experiments were run in triplicate and repeated twice. SDs are indicated. FN (30 Ixg/ml), Ca 140 (20 ~tg/ml), and PDGF (5 ng/ml) were used at the concentrations exerting maximal chemotactic activity (5, 34, 46) as confirmed in preliminary experiments. The two compartments were separated by a polycarbonate flter (8 Ilm pore size; Nuclepore, Concorezzo, Italy) coated with gelatin (5 ~tg/ml; Sigma) an attachment substrate for fibroblasts (42) . Of the chemoattractants used, only FN has been reported to bind to gelatin, and Ca 140 lacks the gelatin-binding domain (45) . In some experiments FN and FN peptides were placed either in the upper, in the lower, or in both compartments of the Boyden chamber, and the migratory activities were compared with those obtained when only the lower compartment contained chemoattractant (57) . Cells were allowed to migrate for 5 h at 37~ in a humidified atmosphere containing 5% CO2 (3). After this time, cells on the upper side of the filter were removed mechanically; the cells on the lower surface of the filter were fixed in ethanol, stained with toluidine blue, and 5 U fields per filter were counted at 160x with a microscope (Zeiss, Oberkochen, FRG). Filters were numbered at the onset of the assay and counted without knowledge of their identity. The fields to be counted were selected randomly from the surface of the migrated cells. One field represents ,'~1/160 of the total area of migrated cells. Each assay was carried out in triplicate and repeated at least twice.
Results

Inhibition of Fibroblast Migration by Antibodies to the Cell-binding Site of FN
It is well known that FN is a potent chemoattractant for fibroblastic cells and that the active region lies within a large fragment (Ca 140) which contains the major cell-binding domain of the molecule (38, 41, 47) . The effect of three monoclonal antibodies which react with this fragment were tested (Table I) . Monoclonals A317 and 3E3 react with the cellbinding site within Ca 140 while A286 recognizes a determinant in a more NH2-terminal region of Ca 140 (16) . Monoclonal antibodies A317 and 3E3 (Table I) as well as (Table I ). These studies indicate that it is a portion of Ca 140 associated with the cell-binding site that is the principal active sequence on FN directing the chemotactic migration of 3T3 cells.
Effect of Synthetic Peptides on Cell Migration
The sequence Arg-Gly-Asp-Ser (RGDS) has been identified as the major cell-binding domain of FN (37, 38, 40) . The possibility that synthetic peptides containing this sequence were chemotactic or could inhibit FN-induced migration was investigated. RGDS alone in the lower compartment of the Boyden chamber at levels up to 1,000 ~tg/ml did not stimulate cell migration (Table II) . In contrast, GRGDSP was found to elicit a dose-dependent response (Fig. 2) . The response was biphasic with a peak of maximal activity observed between 10 -3 and 10 -l laM. A related peptide with glutamic acid substituted for aspartic acid was not chemotactic, nor did it exhibit competitive activity (Table II) at concentrations up to 1 mg/ml. When the RGDS peptide was added in the lower compartment of the Boyden chamber together with FN (Table II) or the Ca 140 peptide (Table III) , a dose-dependent reduction of cell migration was observed. A reduction of FN-induced cell migration was also observed when RGDS was added to the upper compartment (Table II) . In this case maximal activity was achieved with 200 gg/ml. SV3T3 cells were more responsive to the peptides than 3T3 cells (Table  II) . RGDS (Table II) stimulated random migration when added to both compartments. To see if the migration to GRGDSP was mostly chemotactic or chemokinetic, we ran a checkerboard analysis (57) using concentrations of the peptide active in stimulating migration. Table IV shows that the migration of cells in the presence of equimolar concentra- 
Inhibition of CeU Migration by Antibodies to the FN Receptor
To investigate the role of cell surface proteins in the chemotactic response to FN, we used an antiserum (anti-BHK) that inhibits fibroblast attachment and spreading on FN-coated dishes (19) . This antiserum was tested here for its ability to precipitate the FN receptor complex (18, 19) . Under reducing conditions the precipitated material migrated as a diffuse band at Mr 140,000 (Fig. 3) . In the absence of reducing agents, two major components are observed, with molecular masses of 150 and 135 kD, respectively (Fig. 3) . Recent results (Tarone, G., and E Giancotti, unpublished results) indicate that the two polypeptides are parts of a heterodimeric complex. When the anti-BHK antiserum was added to the lower compartment of the Boyden chamber, cell migration toward FN was inhibited in a dose-dependent manner (Fig. 4) . The antibodies did not affect migration of cells towards PDGE a potent chemoattractant (46) known to act Concentrations of GRGDSP active in chemotactic stimulation (Fig. 2) were put in the lower and/or upper compartment. The first column on the left represents chemotaxis, the diagonal represents chemokinetic activity.
through a different receptor (8, 24) . Furthermore, adsorption of the antiserum with partially purified FN receptor resulted in the virtually complete loss of inhibitory activity on cell migration (data not shown). The possibility that antibodies inhibited migration by preventing adhesion of the cells to the upper surface of the filter was ruled out since a concentration of 250 I.tg/ml of antibodies in the lower compartment significantly inhibited migration (50%) without affecting adhesion (data not shown). The antibodies were found to be more Three independent experiments were carried out. Each assay was done in triplicate and did not differ by more than 10%.
effective in preventing FN-induced directional migration of normal than of SV40-transformed cells. As shown in Fig. 4 , in fact, while 200 I~g/ml gave "~50% inhibition of migration of normal 3T3 cells, an approximately twofold higher concentration of the antibodies was necessary to obtain the same degree of inhibition with SV3T3 cells.
Discussion
FN is a potent chemoattractant, particularly for mesenchymal cells, and chemotactic activity resides in a cathepsin D-derived fragment (Mr 140,000) (3, 5, 41, 47) . When coated onto surfaces, this peptide also mediates cell attachment by binding to FN receptors on cell surfaces (5, 47) . Current concepts suggest that chemotaxis is also a receptormediated phenomenon, which allows the cells to detect and migrate along a gradient of a chemotactic factor (2, 6, 12, 22, 24, 36, 49, 56) . Due to the coincidence of attachment and chemotactic activities within the Ca 140 fragment of FN, it seemed possible that they represent different functions mediated via the same recognition system. In the present work, we show that RGDS-containing FN sequences (37, 38, 40) and the 140-kD cell surface receptor (18, 19, 51) known to be involved in cell-substratum adhesion also mediate the migratory response of 3T3 and SV3T3 cells to FN and an FN fragment.
Two monoclonal antibodies (A317 and 3E3), able to block cell attachment by reacting with the portion of Ca 140 close to the cell-attachment site (16, 39) , also inhibit the chemotactic response of the cells to the Ca 140 peptide. Moreover, the synthetic hexapeptide GRGDSP, corresponding to the cellattachment sequence in FN (37, 38, 40) , was able to stimulate both random and chemotactic migration, although its chemotactic activity is lower (i.e., 30%) than that of FN. A shorter peptide, RGDS, was not significantly chemotactic itself, but did reduce chemotaxis to the Ca 140 cell-binding peptide indicating that it can compete in FN-cell recognition. GRGDSP is also a better substrate for adhesion than RGDS (37) . The loss of chemotactic activity of RGDS could be due to a less stable binding of this short peptide. Another possibility is a more rapid diffusion of this small molecule with disruption of the gradient across the filter. FN-mediated cell adhesion appears to occur via cell receptors (1, 9, 11, 13, 15, 21, 23, 25, 35, 43, 50 presented (4, 7, 10, 14, 29) . It is not surprising that antibodies or peptides able to interfere with cell adhesion also prevent migration on a matrix substrate. Our work presents evidence that the cell-binding domain of FN and its receptor are involved in the chemotactic response of fibroblasts to a gradient of FN in solution.
In summary, our data show that the chemotaxis of 3T3 and SV3T3 cells is mediated through the RGDS cell attachment site of FN and through the FN cell surface receptor. The interaction is specific and there is preliminary evidence for its alteration with transformation.
